Clinical Trial Update: XL TDR® eXtreme Lateral Total Disc Replacement for the Treatment of Lumbar Degenerative Disc Disease (DDD) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the XL TDR eXtreme Lateral Total Disc Replacement for lumbar degenerative disc disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Degenerative Disc Disease

Snippet

Sponsor: NuVasive | Conditions: Degenerative Disc Disease | Phase 3 | Status: COMPLETED